Royce & Associates LP Vivos Therapeutics, Inc. Transaction History

Royce & Associates LP

  • $10.3 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021
SELL
$2.71 - $5.9 $943,080 - $2.05 Million
-348,000 Closed
0 $0
Q1 2021

May 10, 2021
BUY
$6.01 - $8.9 $288,480 - $427,200
48,000 Added 16.0%
348,000 $2.31 Million
Q4 2020

Feb 08, 2021
BUY
$5.91 - $9.11 $1.77 Million - $2.73 Million
300,000 New
300,000 $1.77 Million

About Vivos Therapeutics, Inc.

VVOS Quotes by TradingView
  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $60.3M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email